AS MONOTHERAPY OF PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALISATION : BY MOUTH OR BY INTRAVENOUS INFUSION, ADULT AND ADOLESCENT OVER 16 YEARS, INITIALLY 250 MG TWICE DAILY INCREASED ACCORDING TO RESPONSE IN STEPS OF 250 MG TWICE DAILY EVERY 2 WEEKS; MAX. 1.5 G TWICE DAILY
ADJUNCTIVE THERAPY OF PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALISATION, MYOCLONIC SEIZURES, AND TONIC-CLONIC SEIZURES: BY MOUTH OR BY INTRAVENOUS INFUSION, ADULT AND ADOLESCENT OVER 12 YEARS, BODY-WEIGHT OVER 50 KG, INITIALLY 500 MG TWICE DAILY, ADJUSTED IN STEPS OF 500 MG TWICE DAILY EVERY 2 TO 4 WEEKS; MAX. 1.5 G TWICE DAILY; CHILD AND ADOLESCENT 4 - 18 YEARS (12 - 18 YEARS FOR MYOCLONIC AND TONIC-CLONIC SEIZURES), BODY-WEIGHT UNDER 50 KG, INITIALLY 10 MG/KG TWICE DAILY, ADJUSTED IN STEPS NOT EXCEEDING 10 MG/KG TWICE DAILY EVERY 2 WEEKS; MAX. 30 MG/KG TWICE DAILY